SCHEMBL125970

SCHEMBL125970

O=Cc1c(O)c(O)cc2ccccc12

nearest known ligand 0.61

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 9/20 0.61
PADI4 Q9UM07 1/20 0.57
TRPM4 Q8TD43 1/20 0.50
GLO1 Q04760 1/20 0.48
MPL P40238 1/20 0.44
NQO2 P16083 1/20 0.44
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
HTT P42858 1/20 0.41
PTPN22 Q9Y2R2 1/20 0.41
CYP1A2 P05177 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAOB P27338 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29407829 1.00 ERN1 (0.61) ERN1PADI4TRPM4GLO1MPL
SCHEMBL5841822 0.86 ERN1 (0.63) ERN1PADI4TRPM4GLO1NQO2
SCHEMBL10331758 0.85 PADI4 (0.57) ERN1PADI4TRPM4GLO1MPL
SCHEMBL5498368 0.83 ERN1 (0.61) ERN1PADI4TRPM4GLO1MAOB
SCHEMBL15845298 0.82 ERN1 (0.59) ERN1PADI4TRPM4KDM4ENPC1
SCHEMBL13018006 0.81 ERN1 (0.54) ERN1PADI4GLO1HTTCYP1A2
SCHEMBL10504158 0.81 PADI4 (0.53) ERN1PADI4TRPM4GLO1CYP1A2
SCHEMBL11309867 0.81 PADI4 (0.53) ERN1PADI4TRPM4GLO1KDM4E
SCHEMBL5843386 0.81 ERN1 (0.58) ERN1PADI4TRPM4GLO1MPL
Formamide SCHEMBL9731250 0.81 ERN1 (0.45) ERN1PADI4TRPM4GLO1MPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3243238-B1 HYDROTHERMAL TREATMENT METHOD FOR PRODUCING REDOX-ACTIVE TRANSITION METAL COORDINATION COMPOUNDS CRISTAL INORGANIC CHEMICALS SWITZERLAND LTD (CH) 2018-06-06 EP claimed
EP-2018844-A2 Agent for dying fibres which contain keratin comprising derivatives of naphthaldehyde in combination with CH acidic compounds Henkel AG & Co. KGaA (DE) 2009-01-28 EP claimed
CN-115677954-A Covalent organic framework material with air water-collecting performance and preparation method thereof 江南大学 2023-02-03 CN disclosed
CN-111040204-B Force-induced response dynamic polymer and application thereof 厦门天策材料科技有限公司 2023-01-24 CN disclosed
CN-109415304-B Method for producing iron complex and method for producing ester compound using iron complex 株式会社可乐丽 2022-07-22 CN disclosed
CN-111040110-B Force-induced response dynamic polymer and application thereof 厦门天策材料科技有限公司 2022-03-11 CN disclosed
EP-3476828-B1 METHOD FOR PRODUCING IRON COMPLEXES AND METHOD FOR PRODUCING ESTER COMPOUNDS USING IRON COMPLEX KURARAY CO (JP) 2021-03-17 EP disclosed
CN-111171365-A Force-responsive polymer foam composite material 翁秋梅 2020-05-19 CN disclosed
CN-111171364-A Force-responsive polymer foam particle and preparation method thereof 翁秋梅 2020-05-19 CN disclosed
US-10646859-B2 Method for producing iron complexes and method for producing ester compounds using iron complex KURARAY CO., LTD. (JP) 2020-05-12 US disclosed
CN-111040204-A Force-induced response dynamic polymer and application thereof 翁秋梅 2020-04-21 CN disclosed
US-4933399-A COATING INSIDE OF VESSEL WITH A CATIONIC DYE, DRYING, COATING WITH AN ANIONIC OR AMPHOTERIC POLYMER OR A HYDROXYL-CONTAINING COMPOUND IN A SOLVENT SHIN-ETSU CHEMICAL CO., LTD. (JP) 1990-06-12 US disclosed
US-4892923-A Polyester compositions containing the residue of a naphthopyran compound and shaped articles produced therefrom EASTMAN KODAK COMPANY (US) 1990-01-09 US disclosed
CN-1035118-A A kind of method that forms polymer-scale that stops SHINETSU CHEMICAL CO (JP) 1989-08-30 CN disclosed
EP-0320227-A2 Method of preventing polymer-scale formation Shin-Etsu Chemical Co., Ltd. (JP) 1989-06-14 EP disclosed
EP-0218215-A2 Ultraviolet light stable flame retarded polycarbonate blends GENERAL ELECTRIC COMPANY (US) 1987-04-15 EP disclosed
US-4599347-A ANTIULCER AGENTS HOFFMANN-LA ROCHE INC. (US) 1986-07-08 US disclosed
US-4554280-A ANTISECRETORY AGENTS, ANTIULCER AGENTS HOFFMANN-LA ROCHE INC. (US) 1985-11-19 US disclosed
US-4435406-A 2-PYRIDYL DERIVATIVES OF 1,3-DIOXOLO(4,5-F)BENZIMIDAZOLE RING COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 1984-03-06 US disclosed
US-3966678-A Maleic anhydride-polyaldimine prepolymers RHONE-POULENC S.A. (FR) 1976-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10646859-B2 Method for producing iron complexes and method for producing ester compounds using iron complex FECH, FTH1, TFRC ERN1 1282/4885PADI4 711/4885TRPM4 4599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.